1Shapiro AM, Lakey JR, Ryan EA,et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 2000,343: 230-238.
2Lakey JR, Kneteman NM, Rajotte RV, et al. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation, 2002,73: 1106-1110.
3Hering BJ, Matsumoto I, Sawada T, et al. Impact of two-layer pancreas preservation on islet isolation and transplantation.Transplantation, 2002, 74: 1813-1816.
4Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation, 2003, 75: 1524-1527.
5Tsujimura T, Kuroda Y, Churchill TA, et al. Short-term storage of the ischemically damaged human pancreas by the two-layer method prior to islet isolation. Cell Transplant, 2004, 13:67-73.
6Markman JF, Deng S, Desai NM, et al. The use of non-heartbeating donors for isolated pancreatic islet transplantation.Transplantation, 2003, 75: 1423-1429.
7Goss JA, Goodpastor SE, Brunicardi FC, et al. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation, 2004, 77: 462-466.
8Kessler L, Bucher P, Milliat-Guittard L, et al. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network.Transplantation, 2004, 77: 1301-1304.
9Lakey JR, Helms LM, Kin T, et al. Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation, 2001, 72: 565-570.
10Choi SE, Choi KM, Yoon IH, et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol, 2004, 13: 43-53.
二级参考文献7
1[1]Hering MD, Brendel B J, Schultz AO. International islet transplant registry newsletter[M]. Giessen: Justus-Liebig-University of Giessen,1999. 1-20.
2[2]Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation for patients with diabetes [J]. Diabetes Care, 2000, 23 (1):112-6.
3[3]Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [J]. N Engl J Med, 2000, 343 (4):230-8.
4[4]Janjic D, Wollheim CB. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetic assay[J]. Diabetologia, 1992, 35(5):482-5.
5[5]Fabian MC, Lakey JR, Rojotte RV, et al. The efficacy and toxicity of rapamycin in murine islet transplantation: in vitro and in vivo studies [J]. Transplantation, 1993, 56(5): 1137-42.
6[6]Paty BW, Harmon JS, Marsh CL, et al. Inhibitory effects ofimmunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets[J]. Transplantation, 2002, 73(3): 353-7.
8HOPT U T,DROGNITZ O. Pancreas organtram; plantation.Short and long-term resultsin terms of diabetes control [J]. Langenbeeks Arch Surg, 2000,385:379 - 389.
9HERING B J,KANDASWAMY R, HARM ON J V,et al. Transplantation of cultured islets from two-layer prese rved pancreases in type 1 diabetes with anti-CD3 antibody [J ]. Am J Transplant, 2004,4 : 390.
10GABE R A O,FRAGA D W,CALICUTT C S,et al. Improved in vivo pancreatic islet function after prolonged in vitro islet culture [J]. Transplantation,2001,72: 1730- 1736.
